ES
Edward J Sitar
Director

Edward J Sitar insider trades: Timber Pharmaceuticals (TMBR) stock buys and sales

Director, Timber Pharmaceuticals Last trade Nov 23, 2021 21 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2014
4
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Edward reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 23, 2021TMBR↑ Buy$7K
Sep 14, 2021NMTR↑ Buy$18K
Apr 5, 2021NMTR↑ Buy$50K
Dec 15, 2020NMTR↑ Buy$40K
Nov 16, 2016CGIX↓ Sell$5K
Mar 16, 2015CGIX↑ Buy$7K
Dec 12, 2014CGIX↑ Buy$3K
May 21, 2014CGIX↑ Buy$11K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Edward J Sitar's insider trades

Edward J Sitar is a director at Timber Pharmaceuticals (TMBR). Since May 21, 2014, Edward has reported 7 open-market purchases worth $136K and 1 sale worth $5K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (11 filings), other transactions (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TMBR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.